FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matti Sällberg

Research Profile

Living Beings

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequences

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
C Hamsten; M Johansson; Matti Sällberg; M Starkhammar; T A T Tran; Gustaf Ahlén; U Bengtsson; Hans Grönlund; Marianne van Hage
Identification of galactose-α-1,3-galactose in the gastrointestinal tract of the tick Ixodes ricinus; possible relationship with red meat allergy.
Nogol Rahbin; Matti Sällberg; Soo Aleman; Lars Frelin; Rolf Hultcrantz; Erwin D Brenndörfer
Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients.
Gustaf Ahlén; Matti Sällberg; Lars Frelin
Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse models.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matti Sällberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: C Hamsten; M Johansson; Matti Sällberg; M Starkhammar; T A T Tran; Gustaf Ahlén; U Bengtsson; Hans Grönlund; Marianne van Hage
Identification of galactose-α-1,3-galactose in the gastrointestinal tract of the tick Ixodes ricinus; possible relationship with red meat allergy.
Allergy 2013;68(4):549-52.
2013: Nogol Rahbin; Matti Sällberg; Soo Aleman; Lars Frelin; Rolf Hultcrantz; Erwin D Brenndörfer
Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients.
Biochemical and biophysical research communications 2013;433(1):31-5.
2013: Gustaf Ahlén; Matti Sällberg; Lars Frelin
Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse models.
Methods in molecular biology (Clifton, N.J.) 2013;940():239-67.
2012: Anna Pasetto; Matti Sällberg; Lars Frelin; Fredrik Holmström; Volker Lohmann; Gustaf Ahlén; Soo Aleman; Ralf Bartenschlager; Antonio Bertoletti; Anette Brass; Erwin D Brenndörfer; Margaret Chen
TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(9):4510-9.
2012: Erwin D Brenndörfer; Matti Sällberg
Hepatitis C virus-mediated modulation of cellular immunity.
Archivum immunologiae et therapiae experimentalis 2012;60(5):315-29.
2012: Maria F Perdomo; Matti Sällberg; Anders Vahlne
HIV inhibition by CD4 and CCR5-derived glycopeptides.
AIDS research and human retroviruses 2012;28(9):1052-8.
2012: Gustaf Ahlén; Antony Chen; Tina Falkeborn; Lars Frelin; William W Hall; Barbara Roe; Matti Sällberg; Jonas Söderholm
Limited effect on NS3-NS4A protein cleavage after alanine substitutions within the immunodominant HLA-A2-restricted epitope of the hepatitis C virus genotype 3a non-structural 3/4A protease.
The Journal of general virology 2012;93(Pt 8):1680-6.
2012: Erwin D Brenndörfer; Lars Frelin; Soo Aleman; Johannes Bode; Anette Brass; Jonas Söderholm; Matti Sällberg
Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production.
Gut 2012;61(4):589-96.
2012: Anna Pasetto; Matti Sällberg; Anila Yasmeen; Ralf Bartenschlager; Anette Brass; Lars Frelin; Sarene Koh; Volker Lohmann; Markus Maeurer; Isabelle Magalhaes; Margaret Chen
Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.
The Journal of general virology 2012;93(Pt 2):247-58.
2011: Cecilia Söderberg; Joel Marmur; Kristina Eckes; Hans Glaumann; Matti Sällberg; Lars Frelin; Peter Rosenberg; Per Stål; Rolf Hultcrantz
Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2011;119(7):412-20.
2011: Antony Chen; Gustaf Ahlén; Erwin D Brenndörfer; Anette Brass; Fredrik Holmström; Margaret Chen; Jonas Söderholm; David R Milich; Lars Frelin; Matti Sällberg
Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(9):5107-18.
2010: Lars Frelin; Anette Brass; Gustaf Ahlén; Erwin Daniel Brenndörfer; Margaret Chen; Matti Sällberg
Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?
Drug news & perspectives 2010;23(10):647-53.
2010: Nisakorn Witthajitsomboon; Antony Chen; Sasithorn Lorroengsil; Matti Sällberg; Somsak Pantuwatana
Cloning and expression of envelope protein of Thai genotype I strain KE-093 of Japanese encephalitis virus.
The Southeast Asian journal of tropical medicine and public health 2010;41(6):1359-67.
2010: Erwin Daniel Brenndörfer; Malin Weiland; Lars Frelin; Emma Derk; Gustaf Ahlén; Jian Jiao; Johannes Georg Bode; Matti Sällberg
Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C.
Hepatology (Baltimore, Md.) 2010;52(5):1553-63.
2010: Jessica Nyström; Antony Chen; Lars Frelin; Gustaf Ahlén; Sarene Koh; Anette Brass; Darrell L Peterson; Michael Fons; David R Milich; Catharina Hultgren; Matti Sällberg
Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes.
The Journal of infectious diseases 2010;201(12):1867-79.
2010: H S Gill; J Söderholm; Mark R Prausnitz; Matti Sällberg
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.
Gene therapy 2010;17(6):811-4.
2010: Jian Jiao; Jiangbin Wang; Matti Sällberg
Effects of HCV proteins in current HCV transgenic models.
Hepatology research : the official journal of the Japan Society of Hepatology 2010;40(2):115-24.
2009: Malte Kriegs; Tilmann Bürckstümmer; Kyoshi Himmelsbach; Michael Bruns; Lars Frelin; Gustaf Ahlén; Matti Sällberg; Eberhard Hildt
The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo.
The Journal of biological chemistry 2009;284(41):28343-51.
2009: Matti Sällberg; Lars Frelin; Ola Weiland
DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target.
Expert opinion on biological therapy 2009;9(7):805-15.
2009: Erwin Daniel Brenndörfer; Juliane Karthe; Lars Frelin; Patricia Cebula; Andreas Erhardt; Jan Schulte am Esch; Hartmut Hengel; Ralf Bartenschlager; Matti Sällberg; Dieter Häussinger; Johannes Bode
Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase.
Hepatology (Baltimore, Md.) 2009;49(6):1810-20.
2009: G Ahlén; E Derk; M Weiland; J Jiao; N Rahbin; S Aleman; D L Peterson; K Pokrovskaja; D Grandér; L Frelin; Matti Sällberg
Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
Gut 2009;58(4):560-9.
2009: Matti Sällberg
Oral viral infections of children.
Periodontology 2000 2009;49():87-95.
2009: Lars Frelin; Matti Sällberg
A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans.
Genome medicine 2009;1(1):15.
2008: Jessica Nyström; Kristina Cardell; Thora Björg Björnsdottir; Aril Fryden; Catharina Hultgren; Matti Sällberg
Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.
Vaccine 2008;26(47):5967-72.
2008: Maria F Perdomo; Michael Levi; Matti Sällberg; Anders Vahlne
Neutralization of HIV-1 by redirection of natural antibodies.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(34):12515-20.
2008: Kristina Cardell; Britt Akerlind; Matti Sällberg; Aril Frydén
Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.
The Journal of infectious diseases 2008;198(3):299-304.
2008: Norman R Watts; Giovanni Cardone; Joe G Vethanayagam; Naiqian Cheng; Catharina Hultgren; Stephen J Stahl; Alasdair C Steven; Matti Sällberg; Paul T Wingfield
Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.
Journal of molecular biology 2008;379(5):1119-29.
2008: Sasithorn Lorroengsil; Antony Chen; Matti Sällberg; Somsak Pantuwatana
Genetic differences of E gene of a Thai strain of Japanese encephalitis virus that determine small plaque size phenotype but not neurovirulence in suckling mice.
The Southeast Asian journal of tropical medicine and public health 2008;39(3):387-93.
2007: Gustaf Ahlén; Jonas Söderholm; Torunn Elisabeth Tjelle; Rune Kjeken; Lars Frelin; Urban Höglund; Pontus Blomberg; Michael Fons; Iacob Mathiesen; Matti Sällberg
In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(7):4741-53.
2007: Isabelle Desombere; Hans Van Vlierberghe; Ola Weiland; Catharina Hultgren; Matti Sällberg; Juan Quiroga; Vicente Carreño; Geert Leroux-Roels
Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C.
Journal of medical virology 2007;79(6):701-13.
2006: Lars Frelin; Erwin D Brenndörfer; Gustaf Ahlén; M Weiland; Catharina Hultgren; Mats Alheim; Hans Glaumann; Björn Rozell; David R Milich; Johannes Bode; Matti Sällberg
The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.
Gut 2006;55(10):1475-83.
2006: Jonas Söderholm; Gustaf Ahlén; A Kaul; Lars Frelin; Mats Alheim; Christina Barnfield; Peter Liljeström; Ola Weiland; David R Milich; R Bartenschlager; Matti Sällberg
Relation between viral fitness and immune escape within the hepatitis C virus protease.
Gut 2006;55(2):266-74.
2005: Thora B Björnsdottir; Barbara Stanzeit; Matti Sällberg; Arthur Löve; Catharina Hultgren
Changing prevalence of hepatitis B virus genotypes in Iceland.
Journal of medical virology 2005;77(4):481-5.
2005: Margaret Chen; Matti Sällberg; Janice Hughes; Joyce Jones; Luca G Guidotti; Francis V Chisari; Jean-Noel Billaud; David R Milich
Immune tolerance split between hepatitis B virus precore and core proteins.
Journal of virology 2005;79(5):3016-27.
2004: Margaret T Chen; Jean-Noel Billaud; Matti Sällberg; Luca G Guidotti; Francis V Chisari; Joyce Jones; Janice Hughes; David R Milich
A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(41):14913-8.
2004: Catharina Hultgren; Isabelle Desombere; Geert Leroux-Roels; Juan A Quiroga; Vincente Carreno; Bo Nilsson; Ola Weiland; Matti Sällberg
Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.
Journal of hepatology 2004;40(6):971-8.
2004: Lars Frelin; Gustaf Ahlén; Mats Alheim; Ola Weiland; Christina Barnfield; Peter Liljeström; Matti Sällberg
Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
Gene therapy 2004;11(6):522-33.
2003: Annika C Karlsson; Steven G Deeks; Jason D Barbour; Brandon D Heiken; Sophie R Younger; Rebecca Hoh; Meghan Lane-Fall; Matti Sällberg; Gabriel M Ortiz; James F Demarest; Teri Liegler; Robert M Grant; Jeffrey N Martin; Douglas F Nixon
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene.
Journal of virology 2003;77(12):6743-52.
2003: Lars Frelin; Mats Alheim; A Chen; Jonas Söderholm; Björn Rozell; Christina Barnfield; Peter Liljeström; Matti Sällberg
Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo.
Gene therapy 2003;10(8):686-99.
2003: Gabriel Almroth; Fredrik Uhlin; B Ekermo; B Isaksson; B Kaijser; B Andersson; M Hahn-Zoric; Matti Sällberg
Perspectives on hepatitis B infections and the efficacy of vaccination (hepatitis B and pneumococci) in dialysis patients.
Upsala journal of medical sciences 2003;108(1):61-74.
2003: Una Lazdina; Mats Alheim; Jessica Nyström; Catharina Hultgren; Galina Borisova; Irina Sominskaya; Paul Pumpens; Darrell L Peterson; David R Milich; Matti Sällberg
Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent.
The Journal of general virology 2003;84(Pt 1):139-46.
2002: David Wade; Jan-Ingmar Flock; Charlotta Edlund; Ingegerd Löfving-Arvholm; Matti Sällberg; Tomas Bergman; Angela Silveira; Cecille Unson; Louise A Rollins-Smith; Jerzy Silberring; MALCOLM RICHARDSON; Pentti Kuusela; Hilkka Lankinen
Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide.
Protein and peptide letters 2002;9(6):533-43.
2002: Tinghua Cao; Isabelle Desombere; Peter Vanlandschoot; Matti Sällberg; Geert Leroux-Roels
Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B.
The Journal of general virology 2002;83(Pt 12):3023-33.
2002: Miguel A Rico; Juan A Quiroga; Dolores Subirá; Esteban Garcia; Susana Castañón; Matti Sällberg; Geert Leroux-Roels; Ola Weiland; Margarita Pardo; Vicente Carreño
Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.
Journal of hepatology 2002;36(3):408-16.
2002: Matti Sällberg; Janice Hughes; Joyce Jones; Tom R Phillips; David R Milich
A malaria vaccine candidate based on a hepatitis B virus core platform.
Intervirology 2002;45(4-6):350-61.
2001: David R Milich; J Hughes; J Jones; Matti Sällberg; T R Phillips
Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate.
Vaccine 2001;20(5-6):771-88.
2001: Tinghua Cao; Philip Meuleman; Isabelle Desombere; Matti Sällberg; Geert Leroux-Roels
In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model.
Journal of virology 2001;75(23):11449-56.
2001: Mats Alheim; Una Lazdina; David R Milich; Matti Sällberg
Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant.
Journal of immunological methods 2001;258(1-2):157-67.
2001: M Chen; Matti Sällberg; S N Thung; J Hughes; J Jones; David R Milich
Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice.
Antiviral research 2001;52(2):99-111.
2001: Una Lazdina; Tinghua Cao; J Steinbergs; Mats Alheim; Paul Pumpens; Darrell L Peterson; David R Milich; Geert Leroux-Roels; Matti Sällberg
Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Journal of virology 2001;75(14):6367-74.
2001: Tinghua Cao; Una Lazdina; Isabelle Desombere; Peter Vanlandschoot; David R Milich; Matti Sällberg; Geert Leroux-Roels
Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Journal of virology 2001;75(14):6359-66.
2001: Una Lazdina; Catharina Hultgren; Lars Frelin; M Chen; K Lodin; Ola Weiland; Geert Leroux-Roels; Juan A Quiroga; Darrell L Peterson; David R Milich; Matti Sällberg
Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
The Journal of general virology 2001;82(Pt 6):1299-308.
2001: R Halasz; Ola Weiland; Matti Sällberg
GB virus C/hepatitis G virus.
Scandinavian journal of infectious diseases 2001;33(8):572-80.
2001: Cristina de Carvalho Nicacio; Matti Sällberg; Catharina Hultgren; Ake Lundkvist
T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model.
The Journal of general virology 2001;82(Pt 1):129-38.
2000: R Halasz; Matti Sällberg; S Lundholm; G Andersson; B Lager; Hans Glaumann; Ola Weiland
The GB virus C/hepatitis G virus replicates in hepatocytes without causing liver disease in healthy blood donors.
The Journal of infectious diseases 2000;182(6):1756-60.
2000: Una Lazdina; Catharina Hultgren; M Chen; Björn Fischler; Ola Weiland; I K Mushahwar; Matti Sällberg
Humoral and cellular immune responses to the GB virus C/hepatitis G virus envelope 2 protein.
Journal of medical virology 2000;62(3):334-44.
2000: M Chen; Matti Sällberg; S N Thung; J Hughes; J Jones; David R Milich
Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection.
Journal of virology 2000;74(16):7587-99.
2000: J Iroegbu; M Birk; Una Lazdina; Anders Sönnerborg; Matti Sällberg
Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies.
Clinical and diagnostic laboratory immunology 2000;7(3):377-83.
2000: Arthur Löve; M Chen; Matti Sällberg
Changing profile of HIV-1 serotypes in Iceland during 1989-96.
Scandinavian journal of infectious diseases 2000;32(4):445-6.
2000: Z X Zhang; Una Lazdina; M Chen; Darrell L Peterson; Matti Sällberg
Characterization of a monoclonal antibody and its single-chain antibody fragment recognizing the nucleoside Triphosphatase/Helicase domain of the hepatitis C virus nonstructural 3 protein.
Clinical and diagnostic laboratory immunology 2000;7(1):58-63.
1999: Catharina Hultgren; Ola Weiland; David R Milich; Matti Sällberg
Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(6):1575-7.
1999: M Chen; Björn Fischler; Catharina Hultgren; R Halasz; Antal Nemeth; Matti Sällberg
Analysis of GB virus C markers in families over three generations.
Journal of clinical microbiology 1999;37(12):4153-5.
1999: Annika C Karlsson; Hans Gaines; Matti Sällberg; Stefan Lindbäck; Anders Sönnerborg
Reappearance of founder virus sequence in human immunodeficiency virus type 1-infected patients.
Journal of virology 1999;73(7):6191-6.
1999: R Halasz; Björn Fischler; Antal Nemeth; S Lundholm; Matti Sällberg
A high prevalence of serum GB virus C/hepatitis G virus RNA in children with and without liver disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(3):537-40.
1999: R Halasz; LM Barkholt; C Lara; Catharina Hultgren; Y Ando; Ulrika Broomé; Björn Fischler; Antal Nemeth; B G Ericzon; Anders Sönnerborg; Matti Sällberg
Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products.
Gut 1999;44(2):274-8.
1999: Marek Smoluch; Matti Sällberg; Jerzy Silberring
Nanospray mass spectrometry for identification of peptides. Application of a novel interface.
Acta biochimica Polonica 1999;46(2):475-81.
1999: Piotr Suder; Jolanta Kotlinska; Marek Smoluch; Matti Sällberg; Jerzy Silberring
Metabolic fate of nociceptin/orphanin FQ in the rat spinal cord and biological activity of its released fragment.
Peptides 1999;20(2):239-47.
1999: M Chen; Matti Sällberg; Anders Sönnerborg; Ola Weiland; L Mattsson; L Jin; AJ Birkett; D Peterson; David R Milich
Limited humoral immunity in hepatitis C virus infection.
Gastroenterology 1999;116(1):135-43.
1998: M Birk; Jan-Ingmar Flock; Anders Sönnerborg; Matti Sällberg
Coexisting members of HIV-1 p17 gene quasispecies represent proteins with distinct antigenicity and immunogenicity.
AIDS (London, England) 1998;12(15):1973-81.
1998: Catharina Hultgren; David R Milich; Ola Weiland; Matti Sällberg
The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.
The Journal of general virology 1998;79 ( Pt 10)():2381-91.
1998: Matti Sällberg; J Hughes; A Javadian; G Ronlov; Catharina Hultgren; K Townsend; CG Anderson; J O'Dea; J Alfonso; R Eason; Krishna K Murthy; Douglas J Jolly; SM Chang; SJ Mento; David R Milich; WT Lee
Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen.
Human gene therapy 1998;9(12):1719-29.
1998: David Wade; M Palma; I Löfving-Arvholm; Matti Sällberg; Jerzy Silberring; Jan-Ingmar Flock
Identification of functional domains in Efb, a fibrinogen binding protein of Staphylococcus aureus.
Biochemical and biophysical research communications 1998;248(3):690-5.
1998: Antonio Amoroso; M Berrino; L Canale; Maura Cornaglia; Simonetta Guarrera; Gina Mazzola; SILVANA SAVOLDI; Francesco Scolari; Matti Sällberg; M Clementi; A Gabrielli
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?
Journal of hepatology 1998;29(1):36-44.
1998: Ubaldo Visco-Comandini; Catharina Hultgren; Christina Broström; M Birk; S Kim; Matti Sällberg
Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses.
Clinical and diagnostic laboratory immunology 1998;5(4):463-6.
1998: M Chen; Matti Sällberg; Anders Sönnerborg; L Jin; AJ Birkett; D Peterson; Ola Weiland; David R Milich
Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
Hepatology (Baltimore, Md.) 1998;28(1):219-24.
1998: M Birk; Anders Vahlne; Anders Sönnerborg; Matti Sällberg
Nonsynonymous mutations within the human immunodeficiency virus type 1 p17 gene are clustered to sequences binding to the host human leukocyte antigen class I molecules.
AIDS research and human retroviruses 1998;14(3):241-8.
1998: C Lara; R Halasz; Anders Sönnerborg; Matti Sällberg
Detection of hepatitis G virus RNA in persons with and without known risk factors for blood-borne viral infections in Sweden and Honduras.
Journal of clinical microbiology 1998;36(1):255-7.
1998: Matti Sällberg; Catharina Hultgren
Mutations and deletions within the hepatitis B virus core antigen and locations of B cell recognition sites.
The Journal of infectious diseases 1998;177(1):264-5.
1997: Z X Zhang; M Chen; Catharina Hultgren; AJ Birkett; David R Milich; Matti Sällberg
Immune responses to the hepatitis C virus NS4A protein are profoundly influenced by the combination of the viral genotype and the host major histocompatibility complex.
The Journal of general virology 1997;78 ( Pt 11)():2735-46.
1997: Catharina Hultgren; David R Milich; Matti Sällberg
Antibodies to the hepatitis B e antigen (HBeAg) can be induced in HBeAg-transgenic mice by adoptive transfer of a specific T-helper 2 cell clone.
Clinical and diagnostic laboratory immunology 1997;4(5):630-2.
1997: T Kebede; Sven Britton; T Fehniger; Anders Vahlne; Matti Sällberg
Differences in humoral responses to the p24 antigen between Ethiopian and Swedish human immunodeficiency virus type 1-infected patients may suggest influences from a T-helper 2-like phenotype.
Clinical and diagnostic laboratory immunology 1997;4(5):627-9.
1997: K Sherefa; Matti Sällberg; B Johansson; MO Salminen; Anders Sönnerborg
Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: results may be affected by divergent V3 sequences.
Journal of clinical microbiology 1997;35(9):2419-21.
1997: Björn Fischler; C Lara; M Chen; Anders Sönnerborg; Antal Nemeth; Matti Sällberg
Genetic evidence for mother-to-infant transmission of hepatitis G virus.
The Journal of infectious diseases 1997;176(1):281-5.
1997: Matti Sällberg; K Townsend; M Chen; J O'Dea; TA Banks; Douglas J Jolly; SM Chang; WT Lee; David R Milich
Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.
Journal of virology 1997;71(7):5295-303.
1997: K Kilcevska; L Jackevica; J Steinbergs; I Gusars; Matti Sällberg; A Tsimanis
Monoclonal anti-fosB antibody specific for predetermined, nonstructural region of the fosB protein.
Hybridoma 1997;16(3):277-80.
1997: Z X Zhang; David R Milich; Darrell L Peterson; AJ Birkett; Robert Schvarcz; Ola Weiland; Matti Sällberg
Interferon-alpha treatment induces delayed CD4 proliferative responses to the hepatitis C virus nonstructural protein 3 regardless of the outcome of therapy.
The Journal of infectious diseases 1997;175(6):1294-301.
1997: K Townsend; Matti Sällberg; J O'Dea; TA Banks; David A Driver; Sybille L Sauter; SM Chang; Douglas J Jolly; SJ Mento; David R Milich; WT Lee
Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens.
Journal of virology 1997;71(5):3365-74.
1997: M Chen; Anders Sönnerborg; B Johansson; Matti Sällberg
Detection of hepatitis G virus (GB virus C) RNA in human saliva.
Journal of clinical microbiology 1997;35(4):973-5.
1997: Anders Sönnerborg; S Durdevic; J Giesecke; Matti Sällberg
Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993.
AIDS research and human retroviruses 1997;13(4):343-5.
1997: C Lara; Matti Sällberg; B Johansson; I L de Rivera; Anders Sönnerborg
The Honduran human immunodeficiency virus type 1 (HIV-1) epidemic is dominated by HIV-1 subtype B as determined by V3 domain sero- and genotyping.
Journal of clinical microbiology 1997;35(3):783-4.
1997: Y Ando; Anders Sönnerborg; LM Barkholt; AJ Birkett; B G Ericzon; Matti Sällberg
Antibody production against hepatitis C virus core and nonstructural 3 proteins is highly sensitive to deficits in T-cell function.
Clinical and diagnostic laboratory immunology 1997;4(1):104-6.
1996: Matti Sällberg; Z X Zhang; M Chen; L Jin; AJ Birkett; Darrell L Peterson; David R Milich
Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein.
The Journal of general virology 1996;77 ( Pt 11)():2721-8.
1996: Christina Broström; Anders Sönnerborg; S Kim; Matti Sällberg
Site-directed serology of HIV-1 subtype B infection: relation between virus specific antibody levels and disease progression.
Clinical and experimental immunology 1996;106(1):35-9.
1996: M G Isaguliants; S Nordlund; Matti Sällberg; Valerii D Smirnov; U Rudén; Britta Wahren
HIV-1 epitopes exposed by hybrid hepatitis B core particles affect proliferation of peripheral blood mononuclear cells from HIV-1 positive donors.
Immunology letters 1996;52(1):37-44.
1996: Armando Gabrielli; Z X Zhang; G Cherubini; M Candela; SILVANA SAVOLDI; aldo manzin; Massimo Clementi; Antonio Amoroso; Matti Sällberg
Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
Clinical and experimental immunology 1996;105(1):59-64.
1996: J Steinbergs; K Kilchewska; U Lazdina; A Dishlers; Velta Ose; Matti Sällberg; A Tsimanis
Short synthetic CDR-peptides forming the antibody combining site of the monoclonal antibody against RNA bacteriophage fr neutralize the phage activity.
Human antibodies and hybridomas 1996;7(3):106-12.
1995: Armando Gabrielli; P Sambo; Z X Zhang; M Candela; SILVANA SAVOLDI; aldo manzin; Massimo Clementi; Antonio Amoroso; Matti Sällberg; Giovanni Danieli
Humoral immune response and natural killer activity in patients with mixed cryoglobulinemia.
Clinical and experimental rheumatology 1995;13 Suppl 13():S95-9.
1995: Matti Sällberg; M Blixt; Z X Zhang; J Ekstrand
Passive adsorption of immunologically active and inactive synthetic peptides to polystyrene is influenced by the proportion of non-polar residues in the peptide.
Immunology letters 1995;46(1-2):25-30.
1995: A Samuelson; M Forsgren; Matti Sällberg
Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody.
Clinical and diagnostic laboratory immunology 1995;2(3):385-6.
1995: Z X Zhang; M Chen; Anders Sönnerborg; O Weiland; Matti Sällberg
Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins.
The Journal of infectious diseases 1995;171(5):1356-9.
1995: M Chen; Anders Sönnerborg; Matti Sällberg
Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein.
Journal of clinical microbiology 1995;33(3):778-80.
1995: Christina Broström; A Sönnerberg; Matti Sällberg
Human immunodeficiency virus type 1-infected patients with no disease progression display high-avidity antibody production to autologous V3 sequences.
The Journal of infectious diseases 1995;171(2):509-11.
1995: M Chen; Z Yun; Matti Sällberg; Robert Schvarcz; I Bergquist; Helena Berglund; Anders Sönnerborg
Detection of hepatitis C virus RNA in the cell fraction of saliva before and after oral surgery.
Journal of medical virology 1995;45(2):223-6.
1995: David R Milich; Matti Sällberg; T Maruyama
The humoral immune response in acute and chronic hepatitis B virus infection.
Springer seminars in immunopathology 1995;17(2-3):149-66.
1995: Z X Zhang; Z Yun; M Chen; Anders Sönnerborg; Matti Sällberg
Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction.
Journal of medical virology 1995;45(1):50-5.
1994: K Sherefa; Anders Sönnerborg; J Steinbergs; Matti Sällberg
Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis.
Biochemical and biophysical research communications 1994;205(3):1658-64.
1994: Matti Sällberg; K Sherefa; Z X Zhang
The antigen/antibody specificity exchanger: a new peptide based tool for re-directing antibodies of other specificities to recognize the V3 domain of HIV-1 gp120.
Biochemical and biophysical research communications 1994;205(2):1386-90.
1994: Z X Zhang; Anders Sönnerborg; Matti Sällberg
Antigenic structure of the hepatitis C virus envelope 2 protein.
Clinical and experimental immunology 1994;98(3):382-7.
1994: K Sherefa; Matti Sällberg; Anders Sönnerborg
Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
AIDS research and human retroviruses 1994;10(11):1551-6.
1994: Z X Zhang; Anders Sönnerborg; Matti Sällberg
A cell-binding Arg-Gly-Asp sequence is present in close proximity to the major linear antigenic region of HCV NS3.
Biochemical and biophysical research communications 1994;202(3):1352-6.
1994: P Pushko; Matti Sällberg; Galina Borisova; U Ruden; V Bichko; Britta Wahren; Paul Pumpens; Lars O Magnius
Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies.
Virology 1994;202(2):912-20.
1994: Z X Zhang; M Chen; K Wallhagen; J Trojnar; L O Magnius; B Wahren; Matti Sällberg
Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.
Clinical and experimental immunology 1994;96(3):403-9.
1994: Matti Sällberg; P Pumpen; Z X Zhang; Peter Lundholm; I Gusars; U Rudén; Britta Wahren; Lars O Magnius
Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein.
Journal of medical virology 1994;43(1):62-8.
1994: A Samuelson; M Forsgren; B Johansson; B Wahren; Matti Sällberg
Molecular basis for serological cross-reactivity between enteroviruses.
Clinical and diagnostic laboratory immunology 1994;1(3):336-41.
1994: Z X Zhang; M Chen; Anders Sönnerborg; Matti Sällberg
Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.
Clinical and diagnostic laboratory immunology 1994;1(3):290-4.
1994: Matti Sällberg; U Rudén; Britta Wahren; Lars O Magnius
Immune recognition of linear antigenic regions within the hepatitis B pre-C and C-gene translation products using synthetic peptides.
Journal of medical virology 1994;42(1):7-15.
1993: Per-Erik Engström; A Larsson; G Norhagen; C I Edvard Smith; Matti Sällberg; K Helgeland; L Hammarstöm
Specificity and levels of oral and systemic antibodies to Actinobacillus actinomycetemcomitans.
Journal of clinical periodontology 1993;20(10):746-51.
1993: Matti Sällberg; P Pushko; I Berzinsh; V Bichko; P Sillekens; M Noah; Paul Pumpens; Elmars Grens; Britta Wahren; Lars O Magnius
Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences.
The Journal of general virology 1993;74 ( Pt 7)():1335-40.
1993: M Levi; Matti Sällberg; U Rudén; D Herlyn; H Maruyama; H Wigzell; J Marks; Britta Wahren
A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(10):4374-8.
1993: Matti Sällberg; U Rudén; Britta Wahren; Lars O Magnius
Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
Clinical and experimental immunology 1993;91(3):489-94.
1992: A Linde; R Söderström; C I Smith; Matti Sällberg; H Dahl; R Grubb; J Björkander; L Hammarström
Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3.
Clinical and experimental immunology 1992;90(2):199-203.
1992: Matti Sällberg; U Rudén; Britta Wahren; Lars O Magnius
Immunodominant regions within the hepatitis C virus core and putative matrix proteins.
Journal of clinical microbiology 1992;30(8):1989-94.
1992: Matti Sällberg; U Rudén; Britta Wahren; Lars O Magnius
Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site.
Immunology letters 1992;33(1):27-33.
1991: Matti Sällberg; U Rudén; Lars O Magnius; E Norrby; Britta Wahren
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins.
Immunology letters 1991;30(1):59-68.
1991: Matti Sällberg; U Rudén; Britta Wahren; M Noah; Lars O Magnius
Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant.
Molecular immunology 1991;28(7):719-26.
1991: Matti Sällberg; Helene Norder; Gudrun Lindh; Lars O Magnius
IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B.
Clinical and experimental immunology 1991;84(1):116-21.
1991: Matti Sällberg; U Rudén; Lars O Magnius; H P Harthus; M Noah; Britta Wahren
Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen.
Journal of medical virology 1991;33(4):248-52.
1990: Matti Sällberg; Helene Norder; Lars O Magnius
Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B.
Journal of medical virology 1990;30(1):1-6.
1989: Matti Sällberg; Lars O Magnius
Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc.
Journal of clinical microbiology 1989;27(5):849-53.